HALO logo
halo search icon
Amphastar Pharmaceuticals, Inc.

US$18.16

Price Change Indicator
0.08 (0.442%)
Amphastar Pharmaceuticals, Inc.
AMPH · NAS

Amphastar Pharmaceuticals, Inc.

Start Trading AMPH for Free

US$18.16

Price Arrow0.08 (0.442%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapHALO AllHALO ValueHammer BearishHammer Bearish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Amphastar Pharmaceuticals, Inc. Overview

AMPH Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Neutral

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Neutral

About AMPH

icon
icon

Telephone

1.909.980.9484

icon

Address

11570 6th Street, Rancho Cucamonga, CA 91730

Description

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

AMPH Price Chart

Key Stats

Market Cap

US$797.20M

PE

13.20

EV/EBITDA

7.9

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 16.65 - 31.26

Trade Value (12mth)

US$2,951,900.00

1 week

7.17%

1 month

-13.86%

YTD

-31.67%

1 year

-25.29%

All time high

67.66

Key Fundamentals

EPS 3 yr Growth

11.50%

EBITDA Margin

28.30%

Operating Cashflow

$156m

Free Cash Flow Return

11.10%

ROIC

7.00%

Interest Coverage

8.00

Quick Ratio

2.90

Other Data

Shares Outstanding (Fully Diluted)

46m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

AMPH Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
08 May 26
08 May 26

AMPH Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock2.853.292.1locklocklock
EPS (Fully Diluted)
 $locklocklocklock2.63.062.03locklocklock
Growth
 %locklocklocklock51.415.6-36.3locklocklock
PE
 Xlocklocklocklock23.812.113.2locklocklock
EV/EBITDA
 Xlocklocklocklock14.98.87.9locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Amphastar Pharmaceuticals, Inc. (AMPH:NAS)?
Halo FAQ
The current share price of Amphastar Pharmaceuticals, Inc. (AMPH:NAS) is USD$18.16.
What is the 52-week high share price for Amphastar Pharmaceuticals, Inc. (AMPH:NAS)?
Halo FAQ
The 52-week high share price for Amphastar Pharmaceuticals, Inc. (AMPH:NAS) is USD$31.26.
What is the 52-week low share price for Amphastar Pharmaceuticals, Inc. (AMPH:NAS)?
Halo FAQ
The 52-week low share price for Amphastar Pharmaceuticals, Inc. (AMPH:NAS) is USD$16.65.
What is the dividend yield for Amphastar Pharmaceuticals, Inc. (AMPH:NAS)?
Halo FAQ
Amphastar Pharmaceuticals, Inc. (AMPH:NAS) does not pay a dividend.
What was Amphastar Pharmaceuticals, Inc. (AMPH:NAS) last dividend payment?
Halo FAQ
Amphastar Pharmaceuticals, Inc. (AMPH:NAS) does not pay a dividend.
What is the franking level for Amphastar Pharmaceuticals, Inc. (AMPH:NAS)?
Halo FAQ
Amphastar Pharmaceuticals, Inc. (AMPH:NAS) has a franking level of 0.00%.
In which sector is Amphastar Pharmaceuticals, Inc. (AMPH:NAS) classified?
Halo FAQ
Amphastar Pharmaceuticals, Inc. (AMPH:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Amphastar Pharmaceuticals, Inc. (AMPH:NAS)?
Halo FAQ
The current P/E ratio for Amphastar Pharmaceuticals, Inc. (AMPH:NAS) is 13.20.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial